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Most of the major advances in modern virology during the past 25 years have been due 
principally to the development of refined laboratory techniques and tools and have provided 
a fund of new knowledge and information about the nature of viral infection and 
pathogenesis . One group of viruses of interest to dermatologists, the herpesviruses, is 
undergoing intensive biochemical investigation to determine whether it is carcinogenic . As a 
result of the success of the World Health Organization's campaign to eradicate smallpox, it is 
predicted that by the end of 1976, smallpox will have been eradicated. 
Other viruses of dermatologic interest which are now being studied include the agents of 
warts, molluscum contagiosum, cat-scratch disease, and enteroviruses. Current research in 
the field of viral chemotherapy may provide the basis for successfully treating these diseases 
in the future. 
Changing their role from hunters of microbes to 
biochemists probing into the nature of life, virolo-
gists are simultaneously reflecting and leading the 
revolution in biomedical research. By using the 
post-World War II tools of tissue culture, radioac-
tive isotopes, chromatography, density gradient 
centrifugation, and the electron microscope , they 
have acquired a vast knowledge about the way 
viruses infect cells and cause disease. Unexpect-
edly the viruses themselves have emerged as 
powerful probes into the nature of cellular and life 
processes. Because of the necessarily close rela-
tionship between viruses and their host cells, the 
understanding and control of virus infections de-
pend almost wholly on knowledge of cell biochem-
istry. 
Vaccines and sera have been powerful aids in the 
prevention of such viral diseases as polio, measles , 
mumps, rubella, yellow fever , and hepatitis, but 
they are only extensions of the fundamental princi-
ples of Jenner's smallpox vaccine and Pasteur's 
rabies vaccine. Compared with the modern treat-
ment of established diseases by means of spe-
cific chemotherapy, the management of viral dis-
eases lags behind all other forms of chemotherapy 
even those of schizophrenia and cancer. Except for 
a few drugs, such as Marboran for smallpox, 
amantadine for influenza A2 , and possibly iodode-
oxyuridine for herpes simplex of the eye, no effec-
t ive specific antiviral drug for systemic or topical 
use on human skin has been found. 
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A number of cutaneous viral diseases can be 
treated symptomatically or surgically, but even 
here, advances will be predictably slow until a 
great deal more is known about intricate cell 
mechanisms. The empiric, trial-and-error methods 
of screening compounds which produced sulfona-
mides, antibiotics, diuretics, and tranquilizers 
have failed to control virus infections. Perhaps 
useful drugs will be found only when cell biochem-
istry is well enough known to enable us to fashion 
precise "magic bullets" that will kill viruses with-
out affecting the normal cell processes. 
A detailed review of the many volumes and 
thousands of articles that have been written about 
the viruses which attack the skin is not feasible. 
Therefore, we have limited ourselves to a few 
details about each virus which we considered most 
important to dermatologists and future investiga-
tors. The few general references and very recent 
articles are meant to serve as guides to the original 
sources [1-4] . 
SMALLPOX 
The universal dread of smallpox is well justified 
because, despite all modern supportive therapy, 10 
to 25% of those who contract it die . The last 
epidemic occurred in 1972 in Yugoslavia where of 
the 175 people who contracted the disease 35 died. 
At the present time, the only small pockets of 
smallpox remaining are in India, Bangladesh, and 
possibly Ethiopia. Not a single case of smallpox 
has been reported in the United States for more 
than 25 years, but 5 to 10 people per year have died 
and many others have been made seriously ill by 
routine smallpox vaccination. Since 1971, however, 
routine vaccination in the United States and in 
many other countries has ceased. The eradication 
of smallpox is an exciting example of global 
cooperation in sharing the advances of medical 
science, epidemiology, and world politics. 
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-Several years ago experts of the World Health 
Organization (WHO) concluded that smallpox 
could be eradicated by combining existing knowl-
edge with a vigorous campaign in all countries 
where the disease existed. The scientific advances 
of that time seem rather simple now but were 
essential to the success of the campaign. First, 
when lyophylized vaccine supplanted glycerinized 
vaccine, a potent vaccine became available in the 
most remote areas of the world where no refrigera-
tion exists. Second, it was deemed more practical 
and effective to contain outbreaks by vaccinating 
the inhabitants of areas where the disease existed 
than to vaccinate all of the inhabitants of a country 
or a continent. Third, it was discovered that 
smallpox is transmitted only by patients without 
any reservoir in insects or animals. 
Because of the nature of the disease and the 
availability of effective prophylactic vaccines, 
WHO concluded that if total prevention could be 
achieved for one year, the disease would probably 
be abolished. The target date for this campaign 
was the end of 1975. Its incredible success in wiping 
out one of man's greatest scourges proves it to be 
one of the best investments and one of the greatest 
achievements in medical history. 
MOLLUSCUM CONTAGIOSUM 
The pathognomonic lesions of this disease are 
caused by one of the largest viruses that infect man 
[2]. Although the lesions contain millions of virus 
particles, the infectivity of the disease is surpris-
ingly slight. Since most patients have no known 
contact with other patients with the disease, the 
mode of transmission often remains a mystery. 
The incidence varies in different countries and 
with age, increasing noticeably at the time of onset 
of sexual activity. The distribution of cases by age 
follows a bimodal pattern. In children, molluscum 
lesions are scattered haphazardly over the trunk 
and extremities whereas in young adults the le-
sions occur in areas of genital contact and are 
found most commonly at the same age at which 
gonorrhea peaks. Some reports of transmission by 
wrestling and by experimental inoculation have 
appeared, but most often the source of infection is 
unknown. 
Many sophisticated attempts to grow the mol-
luscum virus have failed. The outer layers of the 
virus can be removed by tissue-cultured cells, but 
the DNA does not replicate and the virus does not 
reproduce in vitro. 
Although the individual lesion is a small papule, 
it is probably not a true virus-induced tumor. Once 
removed, molluscum contagiosum lesions rarely 
recur. The best way to treat the disease is to paint 
each lesion very carefully with cantharidin (0.7%) 
in ac'etone and flexible collodion; sometimes the 
lesioris must be covered with adhesive tape for 6 to 
8 hr to get the desired response. Lesions which fail 
to respond or are missed can be re-treated at 
weekly intervals. Painful and multilating surgical 
procedures are rarely necessary. 
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ORF 
Ecthyma contagiosum or orf is also caused by a 
large virus which has been studied with the elec-
tron microscope and in ovine tissue culture cells 
[2]. When contracted from animals, the human 
lesion resembles the chancriform group of anthrax, 
tularemia, and cat-scratch fever; only rarely does it 
cause a generalized vesicular dermatitis. There is 
no specific treatment. 
HERPES VIRUSES 
Because of their diversity, their complex interre-
lationship with their hosts, and the severe di~ease 
they cause, the group of viruses known collectively 
as the herpesviruses poses baffling but challenging 
problems which have prompted a cre.sc~ndo of 
scientific and clinical research [4]. ThIS mterest 
has been heightened by the current theory which 
links herpesviruses with cancer in man and which 
has been corroborated by the fact that herpes-
viruses are known to cause cancer in other species. 
Great strides have been made in understanding the 
nature of herpesviruses, but no effective specific 
treatment has been found. Several new antiherpes-
virus drugs are now being clinically tested. 
Classification and Structure of Herpesviruses 
Most of the animal species studied have one or 
more herpesviruses which are biologically and 
antigenic ally distinct from each other and from the 
herpesviruses of other animals. At least 39 herpes-
viruses are known to infect 22 species of warm - and 
cold-blooded animals [3]. Those which affect man 
are herpes simplex (HSV), varicella-zoster (VZ), 
cytomegalovirus, and the Epstein-Barr virus (EB), 
the cause of infectious mononucleosis and Bur-
kitt's lymphoma. New strains are being discovered 
in other species. 
The fact that herpesviruses, even those from 
diverse species, are morphologically similar makes 
electron microscopic diagnosis possible (Fig. 1). 
Though biologically and antigenically different 
from one another, they are all composed of an 
CAPSID CONTAINING 
(PROTEIN) 
CORE 
-.......,.~ 
(DNA) 
SPIKES 
100 nm 
ENVELOPE 
Protems 
GlycOpt ole'n~ 
ll prds 
FIG. 1. Diagrammatic cross-section of the herpes sim-
plex virus. 
July 1976 
100 
75 
"" ....,
Co-'> 
:z: 
...., 
-' 
-=-...., 
= ~ 
S months 2 years 
AGES 
, 
I , 
, 
, 
, 
,-
I ~ 
15 years 
HERPESVIRUS-l 
VARiCElLA-ZOSTER 
CYTOMEGAlOVIRUS 
EPSTEIN-BARR VIRUS 
HERPESVIRUS-2 
"",--
, 
---_ .... ---'-
---
a du It 
FIG. 2. Course of serum antibodies to herpes viruses . 
icosahedral protein shell (capsid) around a nucleo-
protein core which contains double-stranded DNA. 
The nucleocapsids themselves are enclosed in 
membranous structures which contain glyco-
proteins and proteins. The diameter of the en-
veloped particles is from 100 to 200 nanometers. 
Their complex structure is apparent from the at 
least 47 distinct polypeptides and glycoproteins in 
the envelopes of HSV [12 J. 
Because the HSV and VZ viruses are of major 
interest in dermatology, we are limiting our discus-
sion to them. The HSV and VZ infections in man 
have a few common characteristics. They occur as 
distinctive primary infections, often as acute gin-
givostomatitis with HSV or as chickenpox with VZ 
(Fig. 2). Later, after a variable latent period during 
which the virus remains quiescent in a regional 
ganglion, a recurrent form such as herpes labialis 
or zoster appears . Although high-titered neutraliz-
ing IgG antibodies appear with the infection, 
cell-mediated immunity (eM!) as well as inter-
feron production may also playa role in healing the 
lesions. The details differ somewhat in the differ-
ent clinical entities. 
Herpes Simplex Virus 
Detailed antigenic analysis has separted this 
virus into two distinct antigenic types, HSV -1 and 
HSV -2, which can also be distinguished by chemi-
cal differences in DNA. The two types first infect 
individuals at different times in life and are 
i. ransmitted in different ways . 
The clinical manifestations of herpes simplex 
(Fig. 3) are generally divided into (1) the primary 
infection, which occurs in a subject who has never 
:)een infected before and who therefore has no 
-mtibodies to the virus, and (2) the recurring 
~ nfection, which occurs in those previously infected 
:.tnd with circulating antibodies to the infecting 
Ilrus. 
In the most common form of primary infection 
:HSV -1), which is subclinical and not apparent, 
she infected cells in the oral mucosa produce no 
clinical disease but circulating antibody titer to 
t;he virus increases. In approximately 10 to 15 % of 
children, an acute gingivostomatitis occurs. Pri-
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mary infection also appears as a respiratory infec-
tion, infected eczema, keratoconjunctivitis, or a 
fatal visceral disease of the newborn. 
HSV -2 generally occurs on the genitalia after 
puberty, an indication that it is usually acquired 
by venereal contact. Rarely, an infant can contract 
HSV -2 from its mother's genital tract during birth. 
Although there is some crossover, HSV-1 and 
HSV-2 are immunologically separate. Thus, 
infection with type 1 virus does not protect from a 
mucocutaneous type 2 infection. 
Until recently, recurrent lesions were thought to 
be caused only by reactivation of the latent virus 
(Fig. 4). However, experiments in which normal 
skin was inoculated with live herpesvirus demon-
strated that infectious virus can reinfect a person 
who has high-titered neutralizing antibodies [5 J. 
Thus recurrent lesions from an exogenous source , 
could occur when antibody is present. Since pa-
tients with recurrent herpes have maximum titers 
of neutralizing antibodies in their serum, injecting 
vaccines to increase serum antibodies would ap-
pear to be an irrational treatment . 
Those who handle patients with herpes simplex 
should avoid reinfection of the fingers. Genital 
herpes or cervical lesions can probably occur from 
exogenous reinfections by sexual contact with an 
infected partner. Evidence from human and exper-
imental studies indicates that after peripheral 
infection, the herpes virus lurks in some form in 
the regional nerve ganglia (6 ,7]. Many now believe 
that all recurrent herpes simplex originates in the 
ganglia and spreads distally to the skin. But this 
hypothesis does not answer all the questions . 
Although zoster may well follow this path, it is 
hard to understand how simplex lesions could 
appear on both sides of the face and still come from 
one ganglion. In addition to the bilateral nonder-
matome distribution, experimental reinfections in 
new sites (lip to arm or genitalia to thigh) not 
uncommonly result in spontaneous recurrent le-
sions in these inoculated sites . Do these recur-
rences come from infections lurking in newly 
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FIG. 3. Clinical events associated with herpes simplex 
infection. 
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infected ganglia and somehow are transmitted 
when high-titer neutralizing antibody is present? It 
would seem premature to abandon the skin as one 
of the potential sites of chronic viral genome 
between clinical attacks. Furthermore, if the virus 
were in the ganglia only between attacks, how 
could topical treatment to an active recurrent 
lesion prevent recurrences? 
eMI may be important in recurring infections 
[8-11 J. Although some of the data are contradicto-
ry, patients with recurrent lesions seem to have a 
lower level of eMI between attacks than normal 
seropositive controls. In patients receiving immu-
nosuppressive agents after kidney transplants, 
HSV infections are often progressive [12], but they 
do not seem more common in patients with under-
lying lymphocyte defects [13]. Perhaps it would be 
worthwhile to study methods of increasing eMI in 
carefully controlled clinical trials. 
Early reports of photo chemotherapy of recurrent 
herpes simplex lesions were optimistic, but recent 
controlled studies have not only failed to show any 
benefit over the placebo but have indicated some 
disadvan tages. 
Herpesviruses and Cancer 
Table I is a list of animal tumors caused by 
herpesviruses. EB virus is clearly associated with 
Burkitt's lymphoma, but the relation of HSV-2 to 
carcinoma of the cervix is still under investigation. 
Several lines of evidence suggest that HSV -2 is 
causally related to cervical carcinoma [4 J. Accord-
ing to epidemiologic studies, females with anti-
bodies to HSV-2, which would indicate previous 
infection with the virus, have a higher incidence of 
cervical carcinoma than matched controls. In a 
study of cervical tumor, DNA isolated from the 
tumor contained about 39% of the herpesvirus 
DNA; this experiment, however, has not been 
confirmed. Other evidence comes from studies in 
which antigens produced by herpes simplex virus 
in cell culture are found to be related to antigens in 
Vol. 67, No.1 
cervical tumors or in the circulation of patients 
with tumors. An important piece of evidence is 
that inactivated herpes simplex virus can cause 
cancer in appropriate experimental animal 
models. Herpesviruses inactivated with ultraviolet 
light transformed cells in culture which later 
caused malignant tumors when injected into ani-
mals. The experiment can be repeated with both 
HSV-1 and HSV-2 and also with virus which has 
been inactivated with dyes and visible light. Be-
cause dye plus light makes herpesviruses carcino-
genic in animals and because such treatment has 
not been proved effective in controlled clinical 
trials, most virologists are opposed to such ther-
apy. In summary, although HSV-2 may be related 
to cervical cancer, it should be emphasized that 
only a small fraction of the women harboring 
HSV -2 develop cancer and that other factors are 
undoubtedly very important. 
Treatment of Herpes Infections 
The need for specific active treatment of herpes 
infections has steadily increased. Approximately 
35% of all kidney transplant patients develop 
herpes simplex infections, many of which are 
life threatening [12]. Herpesvirus infections of 
atopic lesions may also pose a threat to life. 
Patients who have frequent recurrent herpes sim-
plex of the face or of the genitalia, as well as women 
with cervical erosions or other forms of cervical 
abnormalities that may be due to herpesvirus infec-
tion, urgently need treatment. 
A large number of drugs have been tested and 
have proved ineffective, if not downright harmful, 
in herpes simplex. As with other virus infections, 
once the disease is clincally apparent, chemother-
apy and even specific antisera are of no benefit. 
(See Table II for symptomatic treatment.) 
Varicella-Zoster Virus 
Two different clinical diseases are caused by the 
VZ virus and appear to result from the immune 
status of the patient at the time the virus manifests 
itself. The primary infection, varicella, probably 
occurs via the upper respiratory tract and, in the 
absence of antibody, spreads hematogenously to 
the skin, mucosa, and deeper tissues. Zoster, on 
the other hand, is presumably caused by the 
recrudescence of the same VZ virus infection later 
in life. The viral agent probably resides in a latent 
form, which has not been found but which proba-
TABLE 1. Herpesuiruses and neoplastic disease 
Species 
Chicken 
Frog 
Monkey 
Rabbit 
Human 
Human 
Tumors 
Marek's disease (lymphoma) 
Lucke's adenocarcinoma 
Lymphoreticular tumors 
Malignant lymphoma 
Burkitt's lymphoma 
Carcinoma cervix 
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TABLE II. Treatment for cutaneous herpes simplex 
Specific 
None proved effective in controlled trials 
Eliminate inciting ("trigger") factor if possible 
Symptomatic 
Early stages-tingling, papules, vesicles 
Apply alcohol, ether, chloroform, or liquid nitrogen 
Open all vesicles and expose to warm lamp 
Later stages-crusting, itching 
Apply emollient ointment or cream 
For mouth lesions 
Viscous lidocaine solution as a rinse 
Severe primary or disseminated cutaneous infection 
Parenteral fluids 
Systemic analgesics 
Agents which may warrant further topical controlled 
trials 
AraA (adenine arabinoside: 9-,B-n-arabinofuranosyl 
adenine) 
Phosphonoacetic acid 
2-Deoxy-n-glucose 
Poly I:C 
bly lies in the dorsal root ganglion cells or skin cells 
and travels from one site to the other. 
VZ virus is highly infectious in human vesicle 
fluid and very easily infects susceptible cells in 
culture. However, such infected cells do not yield 
virus particles with high infectivity, and, therefore, 
VZ virus is difficult to work with in the laboratory. 
Unlike the two distinct antigenic strains of herpes 
simplex virus, the two strains of VZ virus, varicella 
or zoster, cannot be distinguished by antigenic 
means; in fact, very little is known about the 
antigenic makeup of the virus. 
Usually most patients who develop zoster are 
apparently healthy, and no trigger factors can be 
found. However, patients with underlying malig-
nant diseases who are treated with antimetabo-
lites, x-rays, and alkylating agents form a high-risk 
group. They are susceptible to a form of dis-
seminated VZ infection which is sometimes fatal. 
Patients with defects in CMI such as Hodgkin 's 
disease , malignant lymphoma, and chronic lym-
phatic leukemia are more susceptible to zoster, but 
those with humoral defects such as multiple mye-
loma are not [14]. 
Little is known about the role played by CMI or 
nterferon in VZ virus infection. Some patients 
with underlying serious illnesses who developed 
":oster had low levels of cutaneous interferon which 
.vere often associated with viral spread and death. 
Those who were not leukopenic and developed 
nterferon in the vesicle fluid recovered. High 
evels of interferon are found in the vesicle fluid of 
lOrmal subjects with varicella. 
Despite experiments with drugs that affect DNA 
:ynthesis, specific treatment for VZ infection is 
;t ill lacking. Analgesics or a tranquilizer like 
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chlorprothixine give symptomatic relief; trials with 
interferon inducers remain inconclusive. Zoster 
immune globulin (ZIG), which prevents varicella 
in children with an underlying ailment who have 
been exposed to chickenpox, is available from the 
Communicable Disease Center in Atlanta. Once 
clinical disease has appeared, however, it is of no 
benefit for zoster or varicella. 
To reduce the risk of postzoster neuritis , sys-
temic corticosteroids should be given to patients 
over 60 years of age unless there is a strong 
contraindication. Prednisone (120 mg per day for a 
week, 60 mg per day for each of the next 2 weeks) is 
usually recommended [2]. 
WARTS 
Although the human wart virus could not be 
grown outside its natural human host until 1975, 
its natural history and biology are well known. 
Some observations, such as the high incidence of 
warts in slaughter-house workers , remain enig-
matic. In the majority of patients, the lesions 
disappear spontaneously within a year or two of 
initial infection . The success of various forms of 
treatment probably depends to a great extent on 
natural involution. Even after deep destructive 
methods of treatment, approximately one-third of 
the lesions will reappear; therefore, no treatment 
that would produce permanent scars should be 
used. 
The infectious transmission of warts has been 
documented for more than half a century, but not 
until recently was it clear that skin warts and 
genital warts are probably caused by closely re-
lated but different viruses. The recent increase in 
genital warts (1.5 % of obstetrical patients have 
them) has paralleled the increase in gonorrhea and 
other veneral infections. Genital warts in the 
female become large apparently from increasing 
levels of estrogen. Large vulvar warts usually 
indicate pregnancy or serious liver disease ; if they 
become exceptionally large in pregnant women, 
they may be a hazard at delivery because of the 
danger of hemorrhage. Another hazard is to infants 
born of mothers with condyloma acuminatum. 
Such children may develop laryngeal papillomas 
which are apparently caused by the wart virus. If 
these spread, they cause airway obstruction and 
death by suffocation [15]. Another hazard to preg-
nant women that has been reported is the copious 
treatment of moist warts with podophyllin. Ab-
sorption and life-threatening toxicity of the central 
nervous system of the mother and the death of the 
fetus have occurred. Veneral disease centers have 
observed that anal warts and genital warts are 
about equally frequent in both men and women, 
but when perianal warts occur alone without 
genital warts , the vast majority are found in male 
homosexuals, an observation known to the second-
century Romans. 
The treatment of warts has not advanced signifi-
cantly since Mark Twain's day except for the 
simplified advance of liquid nitrogen over burning 
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needles. The use of liquid nitrogen can, however, 
result in the transmission of warts to other sites or 
to other patients from contaminated applicators. 
Although no specific chemotherapy has yet been 
devised', recent studies indicate that topically 
applied 5% fluorouracil, usually with occlusion, 
(danger: onycholysis) is more effective than place-
bos. However, one-third of the lesions fail to clear, 
and onycholysis is always a danger when peri-
ungual warts are treated. Topical bleomycin and 
20% iododeoxyuridine may also prove to be effec-
tive caustics. 
When the human papilloma virus was first 
demonstrated with the electron microscope, it was 
exciting confirmation that this truly is an infec-
tious disease. Despite many attempts, the virus 
could. not be grown in tissue culture or in other 
animals. Purification of the virus by Pass and his 
associates [15] and others has provided very high 
concentrates of virus for immunologic studies and 
cultivation. The immunologic studies with purified 
wart virus antigen have been somewhat contradic-
tory [13,15,16]. Some investigators report that 
circulating antibodies to the wart virus increase as 
the warts disappear, but others suggest that anti-
bodies appear as the infection continues. Many 
patients with warts, even extensive warts, fail to 
develop any detectable antibody by present 
methods, and there is little evidence of any rela-
tionship between circulating antibody and protec-
tion against warts, their duration, or their sponta-
neous involution. The fact that injecting purified 
human virus subcutaneously into guinea pigs regu-
larly results in antibody formation whereas it fails 
to do so in normal epithelial infections suggests 
that antigen often fails to penetrate the epidermis 
in normal infections. There is some evidence that a 
defective immune state such as Hodgkin's disease, 
malignant lymphoma, or chronic lymphatic leu-
kemia may predispose to warts [13], which are 
also more likely to develop in patients with renal 
transplants. Although these groups are more sus-
ceptible, it is not known whether CMI is important 
in natural involution. According to another in-
triguing study with enzyme markers, each wart 
arises from a single clone of cells. This important 
finding should be verified since it could also 
explain the spontaneous dissappearance of one of 
several warts by the senescence of one clone but 
not others in the absence of an immune mecha-
nIsm. 
Eisinger and her co-workers [17] have reported 
on the propagation of human wart virus in tissue 
culture. They provide firm evidence that human 
wart virus multiplied in tissue culture for at least 
14 passages. The techniques of the tissue culture 
seem to be unique; it is to be hoped that the results 
can be promptly confirmed. Lancaster and Menke 
from the Scripps Clinic have reported on the 
persistence of viral DNA in human cell cultures 
infected with human papilloma virus [14]. Al-
though these cells seem to have normal growth and 
morphology, under proper conditions the latent 
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viral DNA might become derepressed and induce 
cell growth similar to that of transformed cells. 
These results would indicate that the ubiquitous 
human wart virus should be seriously considered as 
the agent of other neoplastic diseases in man. At 
any rate, it now seems possible that the viral DNA 
can be transmitted in culture and that an appar-
ently intact infectious virus will be available for 
experimental studies. 
PAPULAR ACRODERMATITIS OF CHILDHOOD 
(AN AUSTRALIA ANTIGEN DISEASE) 
In 1955 Gianotti of Milan described papular 
acrodermatitis of childhood (PAC) and since then 
it has been reported from many other countries 
[18]. It is an infective disease with a recognizable 
papular eruption lasting 20 days or more, reactive 
reticulohistiocytic lymphadenitis that is mainly 
inguinal and axillary, and an acute hepatitis, 
usually anicteric, which commonly lasts about 2 
months. In all cases, Australia antigen is present in 
the blood; it can be detected 10 or more days after 
the onset of the disease and persists from months 
to years afterwards. The children are not usually 
very sick but older ones may develop some icterus. 
The eruption consists of monophoric lenticular, 
flat, erythematopapular, nonitching lesions, sym-
metrically spread over the face, buttocks, and 
limbs. The trunk is usually spared but a transient 
rash may be seen on it in the early eruptive phase. 
The mucous membranes are not affected. 
CAT-SCRATCH DISEASE 
Cat-scratch disease, which is somewhat rare, has 
distinctive and intriguing features. Lee Foshay in 
the United States and Robert Debre in Paris 
studied several cases with characteristic peripheral 
lesions and regional lymph nodes from which they 
prepared a skin test antigen. When the two workers 
exchanged antigens, they found that the American 
antigen was positive in French patients and the 
French antigen active in American patients. Cat-
scratch disease appears to have a single common 
cause, but the many attempts to isolate a virus and 
to find other causative organisms have been unsuc-
cessful. 
Diagnosis is based on the typical clinical course 
because the skin test antigen is not generally 
available. The lesion is a small pink macule to 
papule, usually on the hand, which appears about 
3 to 14 days after inoculation. Usually 3 weeks after 
the primary lesion, adenitis appears, most often in 
the axilla; however, if the primary lesion is missed, 
the adenitis may constitute the whole disease. It is 
never bilateral and is characterized as indolent, 
nearly painless, and varying in size from a cherry 
to an orange. Within a few weeks, it slowly 
reabsorbs but in about half the patients it suppu-
rates and even drains if the pus is not aspirated. As 
a rule, fever and general symptoms occur for brief 
periods. Involvement of the visceral and central 
nervous systems occurs but only rarely. No effec-
tive treatment has been found, but specific sero-
July 1976 
logic tests, as well as a skin test, are available in 
research laboratories which use antigen prepared 
from lymph node pus. Although cats seem to 
transmit the disease, they are not the causative 
agent but play the role of a vector and inoculator. 
In some authentic cases, the patients had had no 
contact with a cat. 
LUPUS ERYTHEMATOSUS 
Although many of the lesions of lupus erythe-
matosus can be accounted for by a process par-
ticipated in by antigen-antibody complexes, sev-
eral studies suggest that certain viruses also play 
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a role in its initiation or pathogenesis. In addition 
to the electron microscopic findings of virus-like 
tubules which, however, were never proved to be 
viruses, several studies in N ZB mice and in dogs 
have implicated viruses. The authors have stressed 
that viral infection cannot be the sole cause of 
lupus erythematosus, especially since the studies 
of NZB mice have demonstrated the importance of 
a genetic factor that could be expressed by an un-
balanced immune system. The lupus-like disease 
of dogs is still being studied and it has been re-
viewed by Schwartz [19]. Zhdanov has reported 
that DNA sequences homologous to the RNA of 
TABLE III. Mucocutaneous patterns in Coxsackie and Echo virus infections a 
Disease 
Herpangina 
Hand, foot and 
mouth disease 
Echo 9 
Skin lesions Mucosal lesions 
Coxsackie Viruses 
Usually none 
Few (2-5) papulovesicles lateral 
proximal border of fingers and 
ulnar borders of hands; many 
tiny vesicles may occasionally 
be seen on palms, feet; similar 
vesicles on toes and lateral bor-
ders. Maculopapular and vesic-
ular lesions common on buttock 
under age 3. 
Few (4-10) vesicles progressing 
to ulcers (3-6 mm) with hyper-
emic border; of mouth and soft 
palate, uvula, anterior pillars, 
pharynx 
Herpangina-like; all areas except 
posterior pharynx 
Maculopapules; petechiae occa- May be herpangina-like 
sionally; urticarial lesions; 
rarely vesicles resembling vari-
cella. First face, trunk, and then 
generalized. 
First face, trunk, and then gener- Usually none 
alized. Maculopapules (morbilli-
form). 
Morbilliform macular and papular 
which appears as fever subsides 
(like roseola) . First face, trunk, 
then generalized. 
Vesicular, pharyngitis with type 
5 
Echo Viruses 
Maculopapular, sometimes vesic- Occasionally punched-out ulcers 
ular. If petechial, look for men in- on soft palate and tonsillar pil-
gococcemla. Face, neck, then lars; grayish or white dots sim-
generalized. ulating Koplik's spots 
. ~oston exanthem Maculopapular rash appears as 
febrile response diminishes. 
First face, neck, then general-
ized. 
Punched-out ulcers on soft palate 
and tonsillar pillars 
9, 4, 
Virus group 
and type 
A 
9, 2,4, 5 
A 
16,5 
A 
9 
A 
4 
B 
1, 3,4,5 
6, 14, 18 
others cause 
thema and/or 
cles) 
(and 
ery-
vesi-
16, 1, 2, 3, 5,7, 1l, 19 
a Derived in part from: Debre R, Celers J: Clinical Virology, Philadelphia, Saunders, 1970, pp 374-384. 
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measles virus were found in tissues affected with 
systemic lupus erythematosus. Integrated viral 
genomes of such paramyxoviruses as measles could 
be expressed by synthesizing cell membranes with 
altered antigenic properties which would then be-
come targets for the host's immunocompetent T-
cells and would trigger autoimmune disease [20]. 
ENTERO VIRUSES 
In Table III, the multitude of mucocutaneous 
lesions associated with Coxsackie and Echo viruses 
are tabulated. 
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